make power point out of this paper

This study explores the role of germline genetic testing in prostate cancer, adhering to NCCN guidelines. It presents survey-based findings on testing practices, prioritised populations, and completion rates. Challenges, including barriers and strategies like systematic family testing, are identified. Future directions stress addressing systemic obstacles and advancing interventions to improve outcomes.